TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis.

Area of Science:

• Genetics
• Pulmonology
• Immunology

Background:

• Pulmonary fibrosis is a common symptom of telomere syndromes.
• Mutations in telomere genes, including TINF2, are implicated in both familial and sporadic forms of the disease.
• The TINF2 gene product is crucial for telomere protection and maintenance within the shelterin complex.

Purpose of the Study:

• To report the first identified TINF2 gene mutation in a patient with sporadic pulmonary fibrosis.
• To investigate the association between TINF2 mutations and pulmonary fibrosis.
• To highlight hypogammaglobulinemia as a potential manifestation of telomere syndromes.

Main Methods:

• Genetic sequencing to identify mutations in the TINF2 gene.
• Clinical evaluation and retrospective multidisciplinary assessment for pulmonary fibrosis.
• Telomere length measurement in peripheral blood cells.

Main Results:

• A heterozygous Ser245Tyr mutation in the TINF2 gene was identified in a patient with sporadic pulmonary fibrosis and panhypogammaglobulinemia.
• The patient presented with progressive cough and was classified as possible idiopathic pulmonary fibrosis.
• Peripheral blood telomere length was normal, suggesting telomere dysfunction rather than solely length is critical.

Conclusions:

• This case represents the first instance of a TINF2 mutation associated with sporadic pulmonary fibrosis.
• TINF2 mutations are linked to pulmonary fibrosis, emphasizing telomere dysfunction in telomere syndromes.
• Hypogammaglobulinemia should be recognized as a potential clinical feature of telomere syndromes.